Skip to content

Role of homoeopathic medicine in chronic migraine.

The effectiveness of individualized homoeopathic treatment on chronic migraine associated with stress and anxiety using MIDAS scale : an open label, prospective, clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097134
Enrollment
40
Registered
2025-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G43- Migraine

Interventions

Intervention1: Individualized Homoeopathic Medicine.: Individualized Homoeopathic Medicine will be given based on case taking for every patient for a period of 6months and potency repetition will be d

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants who are diagnosed with chronic migraine according to ICHD – 3 criteria. Participants diagnosed with chronic migraine with stress or anxiety or both. Participants of age between 18 to 50 years of age. Participants who are willing to participate with informed consent in the study. Participants who can able to understand and communicate.

Exclusion criteria

Exclusion criteria: Participants who are diagnosed with an unstable mental or psychiatric illness. Participants suffering from serious systematic disorders or life-threatening diseases. Pregnant or lactating women. Migraine due to estrogen based hormonal therapeutics like oral contraceptive pills (OCPs), hormonal replacement therapy (HRT). Immune-compromised diseased conditions.

Design outcomes

Primary

MeasureTime frame
MIDAS scaleTimepoint: Base line, 3rd month, 6th month.

Secondary

MeasureTime frame
PSS-14 BAI-21Timepoint: Base line, 3rd month, 6th month.

Countries

India

Contacts

Public ContactDR BONELA SIRISHA

National Institute of Homoeopathy

drgautampal@gmail.com9433902556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026